Literature DB >> 25432361

Secondary osteoporosis: pathophysiology & diagnosis.

Gregory R Emkey1, Sol Epstein2.   

Abstract

Osteoporosis is a skeletal disease characterized by decreased bone mass and microarchitectural changes in bone tissue that increase the susceptibility to fracture. Secondary osteoporosis is loosely defined as low bone mineral density or increased risk of fragility fracture caused by any factor other than aging or postmenopausal status. The purpose of this review is to discuss the current understanding of the pathophysiology and contribution to fracture risk of many of the more common causes of secondary osteoporosis, as well as diagnostic considerations, outlined by organ system. While not comprehensive, included are a wide array of diseases, conditions, and medications that have been associated with bone loss and susceptibility to fractures. The hope is to highlight the importance to the general clinician of screening for and treating the osteoporosis in these patients, so to limit the resultant increased morbidity associated with fractures.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  aromatase inhibitors; fragility fractures; glucocorticoids; hypercalciuria; hyperparathyroidism; hyperthyroidism; multiple myeloma; osteoporosis; secondary osteoporosis; vitamin D deficiency

Mesh:

Year:  2014        PMID: 25432361     DOI: 10.1016/j.beem.2014.07.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  12 in total

Review 1.  The Vestibular System: A Newly Identified Regulator of Bone Homeostasis Acting Through the Sympathetic Nervous System.

Authors:  G Vignaux; S Besnard; P Denise; F Elefteriou
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096

2.  Risk of osteoporosis and fracture in victims with burn injury.

Authors:  O Kaewboonchoo; F C Sung; C L Lin; H C Hsu; C T Kuo
Journal:  Osteoporos Int       Date:  2019-02-08       Impact factor: 4.507

Review 3.  Nanotechnology Treatment Options for Osteoporosis and Its Corresponding Consequences.

Authors:  Donglei Wei; Jinsuh Jung; Huilin Yang; David A Stout; Lei Yang
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

4.  The Association between Polypharmacy and Hip Fracture in Osteoporotic Women: A Nested Case-Control Study in South Korea.

Authors:  Hae-Young Park; Suji Kim; Hyun Soon Sohn; Jin-Won Kwon
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

5.  Association between high levels of gynoid fat and the increase of bone mineral density in women.

Authors:  S Aedo; J E Blümel; R M Carrillo-Larco; M S Vallejo; G Aedo; G G Gómez; I Campodónico
Journal:  Climacteric       Date:  2019-11-18       Impact factor: 3.024

6.  β‑Ecdysterone promotes autophagy and inhibits apoptosis in osteoporotic rats.

Authors:  Yang-Hua Tang; Zhen-Shuang Yue; Da-Wei Xin; Lin-Ru Zeng; Zhen-Fei Xiong; Zhong-Qing Hu; Can-Da Xu
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952

7.  Sprint Interval Training Induces A Sexual Dimorphism but does not Improve Peak Bone Mass in Young and Healthy Mice.

Authors:  Kathrin Koenen; Isabell Knepper; Madlen Klodt; Anja Osterberg; Ioannis Stratos; Thomas Mittlmeier; Tina Histing; Michael D Menger; Brigitte Vollmar; Sven Bruhn; Brigitte Müller-Hilke
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

8.  Young and healthy C57BL/6 J mice performing sprint interval training reveal gender- and site-specific changes to the cortical bone.

Authors:  Robin Hollinski; Anja Osterberg; Stefan Polei; Tobias Lindner; Daniel Cantré; Thomas Mittlmeier; Brigitte Vollmar; Sven Bruhn; Brigitte Müller-Hilke
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

Review 9.  Bone Health in Adrenal Disorders.

Authors:  Beom Jun Kim; Seung Hun Lee; Jung Min Koh
Journal:  Endocrinol Metab (Seoul)       Date:  2018-03

10.  Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates.

Authors:  Tetsuya Kaneko; Koichi Okamura; Yukio Yonemoto; Chisa Okura; Takahito Suto; Masahiro Tachibana; Hideo Sakane; Makoto Inoue; Hirotaka Chikuda
Journal:  J Exp Orthop       Date:  2019-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.